Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
272,5 USD | +2,32% | +2,98% | -4,39% |
10/06 | Zwitserse aandelen flitsen rood nu besluit Fed in de schijnwerpers staat | MT |
10/06 | Roche's medicijn tegen longkanker boekt EU-overwinning na 'ongekende' studieresultaten in late stadia | MT |
Omzet 2024 * | 60,39 mld. 67,47 mld. 62,41 mld. | Omzet 2025 * | 63,83 mld. 71,32 mld. 65,96 mld. | Marktkapitalisatie | 197 mld. 220 mld. 203 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 13,26 mld. 14,82 mld. 13,7 mld. | Nettowinst (verlies) 2025 * | 14,76 mld. 16,49 mld. 15,25 mld. | EV/omzet 2024 * | 3,49 x |
Nettoschuld 2024 * | 13,77 mld. 15,39 mld. 14,23 mld. | Nettoschuld 2025 * | 7,5 mld. 8,38 mld. 7,75 mld. | EV/omzet 2025 * | 3,2 x |
K/w-verhouding 2024 * |
14,3
x | K/w-verhouding 2025 * |
12,9
x | Werknemers | 103.605 |
Dividendrendement 2024 * |
4,02% | Dividendrendement 2025 * |
4,14% | Vrij verhandelbaar | 88,91% |
Recentste transcriptie over Roche Holding AG
1 dag | +2,32% | ||
1 week | +2,98% | ||
Lopende maand | +9,71% | ||
1 maand | +11,08% | ||
3 maanden | -2,47% | ||
6 maanden | -5,46% | ||
Lopend jaar | -4,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 01-01-03 | |
Severin Schwan
CHM | Chairman | 57 | 01-01-08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01-04-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03-03-15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01-01-96 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
12-06-24 | 272,5 | +2,32% | 39 836 |
11-06-24 | 266,3 | -0,48% | 4 180 |
10-06-24 | 267,6 | +2,13% | 14 858 |
07-06-24 | 262 | -2,16% | 1 746 |
06-06-24 | 267,8 | +1,21% | 113 |
uitgestelde koers OTC Markets, 12 juni 2024 om 21:13 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+48,79% | 780 mld. | |
+41,76% | 627 mld. | |
+19,43% | 334 mld. | |
+7,18% | 296 mld. | |
+17,60% | 244 mld. | |
+11,54% | 214 mld. | |
+4,53% | 161 mld. | |
-3,92% | 159 mld. | |
-0,51% | 121 mld. |